Therefore, NLRP3/ASC/caspase-1 signaling pathways are implicated in the neuroinflammatory effects of Alzheimer’s disease [52,76,77,78]. The gene discussed is CASP1; the disease is early-onset autosomal dominant Alzheimer disease.